• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗癌药物研究之十四:自旋标记硫代三乙撑磷酰胺(SL-O-TT)的血浆药代动力学及组织分布

On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).

作者信息

Gutierrez P L, Cohen B E, Sosnovsky G, Davis T A, Egorin M J

出版信息

Cancer Chemother Pharmacol. 1985;15(3):185-91. doi: 10.1007/BF00263883.

DOI:10.1007/BF00263883
PMID:2996798
Abstract

We defined the plasma and tissue concentrations and pharmacokinetics of SL-O-TT, a spin-labeled analog of thio-TEPA, in 35-44-g male Swiss Webster mice that had received spin-labeled thio-TEPA at a dosage of 10 mg/kg. Concentrations of spin-labeled thio-TEPA in ethyl acetate extracts of tissue and plasma were determined by gas-liquid chromatography and electron spin resonance spectroscopy. Plasma concentrations of spin-labeled thio-TEPA declined in a biexponential fashion that was well described by the equation: Ct = 21.5e-0.276t + 2.30e-0.026t indicating a half-life alpha of 2.5 min and a half-life beta of 26.6 min. After 2 h there was still spin-labeled thio-TE-PA in plasma, but not in tissues. In tissues, no spin-labeled thio-TEPA was detected with gas-liquid chromatography 15 min after injection, but with electron-spin resonance label was found in lung and skeletal muscle. The main metabolite of spin-labeled thio-TEPA is spin-labeled TEPA, where oxidative desulfurization is invoked as the main metabolic mechanism. Reduction of the spin label to the hydroxylamine was also observed with time.

摘要

我们测定了硫替派的自旋标记类似物SL-O-TT在体重35 - 44克的雄性瑞士韦伯斯特小鼠体内的血浆和组织浓度及药代动力学,这些小鼠接受了剂量为10毫克/千克的自旋标记硫替派。通过气液色谱法和电子自旋共振光谱法测定组织和血浆乙酸乙酯提取物中自旋标记硫替派的浓度。自旋标记硫替派的血浆浓度呈双指数下降,可用方程Ct = 21.5e-0.276t + 2.30e-0.026t很好地描述,表明α半衰期为2.5分钟,β半衰期为26.6分钟。2小时后,血浆中仍有自旋标记硫替派,但组织中没有。在组织中,注射后15分钟用气液色谱法未检测到自旋标记硫替派,但用电子自旋共振法在肺和骨骼肌中发现了标记物。自旋标记硫替派的主要代谢产物是自旋标记替派,主要代谢机制是氧化脱硫。随着时间的推移,还观察到自旋标记物还原为羟胺。

相似文献

1
On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).新型抗癌药物研究之十四:自旋标记硫代三乙撑磷酰胺(SL-O-TT)的血浆药代动力学及组织分布
Cancer Chemother Pharmacol. 1985;15(3):185-91. doi: 10.1007/BF00263883.
2
Plasma pharmacokinetics and tissue distribution of thiotepa in mice.
Cancer Treat Rep. 1984 Oct;68(10):1265-8.
3
Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.噻替派及其代谢产物的人体血浆药代动力学和尿排泄情况。
Cancer Treat Rep. 1986 Jul;70(7):859-64.
4
Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.N,N',N''-三乙烯硫代磷酰胺的生物转化:氧化脱硫生成N,N',N''-三乙烯磷酰胺,并与苯巴比妥诱导的肝P-450单加氧酶的自杀失活相关。
Cancer Res. 1990 Feb 1;50(3):464-71.
5
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.硫替派在卵巢癌患者中的单剂量和重复剂量药代动力学。
Cancer Chemother Pharmacol. 1987;19(2):143-8. doi: 10.1007/BF00254567.
6
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients.硫替派静脉推注给药后,卵巢癌患者体内硫替派、替派的长期药代动力学及总烷基化活性
Cancer Chemother Pharmacol. 1990;25(4):257-62. doi: 10.1007/BF00684882.
7
Cellular pharmacology of N,N',N''-triethylene thiophosphoramide.
Cancer Lett. 1988 Aug 15;41(2):157-68. doi: 10.1016/0304-3835(88)90112-7.
8
Preparation of spin-labeled analogs of the antitumor agents TEPA and thio-TEPA.抗肿瘤药物替派(TEPA)和硫代替派(thio - TEPA)的自旋标记类似物的制备。
Z Naturforsch C. 1973 Nov-Dec;28(11):781-2. doi: 10.1515/znc-1973-11-1231.
9
In the search for new anticancer drugs XI. Anticancer activity of nitroxyl labeled phosphoric N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(TEPA) and phosphorothioic N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(thio-TEPA) derivatives.新型抗癌药物的研究之十一。硝酰基标记的磷酸N,N;N',N';N",N"-三[1,2 - 乙二基]三酰胺(TEPA)和硫代磷酸N,N;N',N';N",N"-三[1,2 - 乙二基]三酰胺(硫代TEPA)衍生物的抗癌活性
Cancer Lett. 1985 Jan;25(3):255-60. doi: 10.1016/s0304-3835(15)30004-5.
10
Gender aspects of liver slice incubations with N,N,N-triethylene-thiophosphamide (Thio-TEPA) in rats and mice.大鼠和小鼠肝脏切片与N,N,N-三乙烯硫代磷酰胺(噻替派)孵育的性别差异
Pharmacol Toxicol. 1999 Mar;84(3):122-4. doi: 10.1111/j.1600-0773.1999.tb00886.x.

本文引用的文献

1
[ANTI-TUMOR ACTIVITY OF FREE STABLE RADICALS].[游离稳定自由基的抗肿瘤活性]
Dokl Akad Nauk SSSR. 1964 Jun 21;157:707-9.
2
Bladder carcinoma treated by direct instillation of thio-TEPA.
J Urol. 1962 Jul;88:60-3. doi: 10.1016/S0022-5347(17)64739-6.
3
Metabolic studies of 32P-labelled triethylenethiophosphoramide.32P标记的三乙烯硫代磷酰胺的代谢研究。
Biochem Pharmacol. 1959 Dec;3:42-50. doi: 10.1016/0006-2952(59)90007-3.
4
Thiotepa in the treatment of tumours of the bladder.
Lancet. 1961 Sep 16;2(7203):615-8. doi: 10.1016/s0140-6736(61)90304-x.
5
Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate.
Cancer Treat Rep. 1982 Jul;66(7):1549-51.
6
One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapy.
Cancer. 1981 Oct 1;48(7):1522-7. doi: 10.1002/1097-0142(19811001)48:7<1522::aid-cncr2820480709>3.0.co;2-g.
7
Plasma pharmacokinetics and tissue distribution of thiotepa in mice.
Cancer Treat Rep. 1984 Oct;68(10):1265-8.
8
Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
J Urol. 1969 May;101(5):711-5. doi: 10.1016/s0022-5347(17)62408-x.
9
The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.局部应用噻替派对浅表性膀胱癌复发率的影响。
J Urol. 1968 Jun;99(6):740-3. doi: 10.1016/S0022-5347(17)62782-4.
10
Toxicity, antitumor activity, and pharmacokinetics of spin-labeled thioTEPA analogs.
Cancer Treat Rep. 1976 Nov;60(11):1605-9.